MedDataX Logo

Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.

NCT01709422 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2013-10-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare efficacy and safety of combination of propofol and midazolam with meperidine versus midazolam and meperidine for ambulatory ERCP

Conditions

  • Disorders of Gallbladder, Biliary Tract and Pancrease

Interventions

DRUG

Propofol

Propofol is the sedative drug used as an additional sedation to one of the study arm.

DRUG

Midazolam

Midazolam is one of the two conventional sedative drugs included in both arms.

DRUG

Meperidine

Meperidine is one of the two conventional sedative drugs included in both arms.

Sponsors & Collaborators

  • Prince of Songkla University

    lead OTHER

Principal Investigators

  • Nisa Netinatsunton, MD · NKC Institute of Gastroenterology and Hepatology, Prince of Songklanakarind University

  • Nisa Netinatsunton, MD · Prince of Songkla University

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Thailand

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01709422 on ClinicalTrials.gov